Voluson Expert 18; Voluson Expert 20; Voluson Expert 22

K242168

GE Medical Systems Ultrasound and Primary care Diagnostics · cleared 2024-12-20 · product code IYN · Radiology

Premarket evidence — what FDA accepted

Device typehardware with ml
source quote (p.5)
The systems are full-featured Track 3 ultrasound systems, primarily for general radiology use and specialized for OB/GYN with particular features for real-time 3D/4D acquisition. They consist of a mobile console with keyboard control panel; color LCD/TFT touch panel, color video display and optional image storage and printing devices. They provide high performance ultrasound imaging and analysis and have comprehensive networking and DICOM capability. They utilize a variety of linear, curved linear, matrix phased array transducers including mechanical and electronic scanning transducers, which provide highly accurate real-time three-dimensional imaging supporting all standard acquisition modes. The proposed Voluson Expert Series 18/20/22 adds additional AI software features SonoLyst 1st Trimester and Sono Pelvic floor 3.0: which includes MHD (valsava manoeuver detection) and Anal sphincter
AlgorithmAI software features SonoLyst 1st Trimester, Sono Pelvic floor 3.0 (MHD, Anal sphincter), SonoLyst 2nd Trimester, and SonoAVC follicle 2.0.
source quote (p.7)
The proposed Voluson Expert Series 18/20/22 adds additional AI software features SonoLyst 1st Trimester and Sono Pelvic floor 3.0: which includes MHD (valsava manoeuver detection) and Anal sphincter The proposed Voluson Expert Series 18/20/22 updated existing AI software features SonoLyst 2nd Trimester and SonoAVC follicle 2.0
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedYes
source quote (p.19)
AAMI TIR69:2017/(R2020), Risk management of radio-frequency wireless coexistence for medical devices and systems

Validation studies (5)

Retrospective clinical

n=93 cases

endpoints: success rate

Retrospective clinical

n=106 cases

endpoints: success rate

Retrospective clinical

n=138 cases

endpoints: success rate; Accuracy; Dice Coefficient

Retrospective clinical

n=2,200,000 images

endpoints: average agreement; average success rate

Retrospective clinical

n=35,861 patients

endpoints: average agreement; acceptability rate; average success rate

Reported performance (9 observations)

accuracyas written: “SonoAVC Follicle 2.0 Accuracy (test data with train cohort)0.9473
source quote (p.12)
On test data acquired together with train cohort: 94.73%
accuracyas written: “SonoAVC Follicle 2.0 Accuracy (test data post model development)0.928
source quote (p.12)
On test data, acquired consecutively post model development: 92.8%
accuracyas written: “SonoAVC Follicle 2.0 Overall Accuracy0.936
source quote (p.12)
Overall Accuracy: 93.6%
diceas written: “SonoAVC Follicle 2.0 Dice Coefficient (3-5mm)0.937619
source quote (p.13)
3-5 0.937619
diceas written: “SonoAVC Follicle 2.0 Dice Coefficient (5-10mm)0.946289
source quote (p.13)
5-10 0.946289
diceas written: “SonoAVC Follicle 2.0 Dice Coefficient (10-15mm)0.962315
source quote (p.13)
10-15 0.962315
diceas written: “SonoAVC Follicle 2.0 Dice Coefficient (>15mm)0.93206
source quote (p.13)
>15 0.93206
accuracyas written: “SonoLyst 2nd Trimester IR and X and overall traffic light accuracystated without valueCI 80% or higher
source quote (p.15)
The average success rate of SonoLyst 2nd Trimester IR and X and overall traffic light accuracy is 80% or higher
accuracyas written: “SonoLyst 1st Trimester IR, X and SonoBiometry CRL and overall traffic light accuracystated without valueCI 80% or higher
source quote (p.17)
The average success rate of SonoLyst 1st Trimester IR, X and SonoBiometry CRL and overall traffic light accuracy is 80% or higher

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

85
recalls in product code, 24mo
554
MAUDE reports in code, 12mo
+85%
vs code's own 3-yr baseline
5
drift signals on this device
  • recall_reason_pattern

    Software/algorithm-related recall in product code IYN (GE Medical Systems, LLC, initiated 2025-09-18): "The Ultrasound-Guided Attenuation Parameter (UGAP) measurement data may display inaccurate values representing liver steatosis. This could potentially lead to inappropriate clinica" Recalling firm matches this device's applicant.

    first seen 2026-07-08 · recall res_event_number:97726

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K252328 (decision 2025-11-24) from Ge Medical Systems Ultrasound and Primary Care Diagnostics for a matching device line ("Voluson Expert 18; Voluson Expert 20; Voluson Expert 22") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K252328

  • recall_reason_pattern

    Software/algorithm-related recall in product code IYN (Philips Ultrasound, LLC, initiated 2025-10-31): "Ultrasound system compatibility issues with Apple devices running iOS 18 may cause a failure to perform live imagining." Recalling firm is another firm in the same product code.

    first seen 2026-07-08 · recall res_event_number:97843

  • recall_reason_pattern

    Software/algorithm-related recall in product code IYN (GE Medical Systems China Co., Ltd. Dev. Zone National Hi-Tech; No., initiated 2025-05-16): "GE HealthCare has become aware that the Estimated Fetal Weight (EFW) measurement data feature on the Versana Premier R3 and LOGIQ F R3 series ultrasound systems can display previou" Recalling firm is another firm in the same product code.

    first seen 2026-07-08 · recall res_event_number:96992

  • recall_reason_pattern

    Software/algorithm-related recall in product code IYN (Siemens Medical Solutions USA, Inc., initiated 2024-08-15): "If ultrasound systems with software, are changed from factory default to : 1) Milliliters per second (ml/sec, mL/sec) or 2) Milliliters per minute (ml/min, mL/min); then systems wi" Recalling firm is another firm in the same product code.

    first seen 2026-07-08 · recall res_event_number:95254

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K242168